Network Meta-Analysis of Pharmacological Agents for Osteoporosis Treatment and Fracture Prevention | Zendy

Xucheng Yang | Zendy; Zhenhan Deng | Zendy; Ting Wen | Zendy; Wei Luo | Zendy; Wenfeng Xiao | Zendy; Ruibo Zhao | Zendy; Yusheng Li | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Network Meta-Analysis of Pharmacological Agents for Osteoporosis Treatment and Fracture Prevention

Author(s) -

Xucheng Yang,

Zhenhan Deng,

Ting Wen,

Wei Luo,

Wenfeng Xiao,

Ruibo Zhao,

Yusheng Li

Publication year - 2016

Publication title -

cellular physiology and biochemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.486

H-Index - 87

eISSN - 1421-9778

pISSN - 1015-8987

DOI - 10.1159/000453138

Subject(s) - teriparatide , denosumab , medicine , zoledronic acid , osteoporosis , adverse effect , placebo , meta analysis , osteonecrosis of the jaw , odds ratio , surgery , urology , bisphosphonate , bone mineral , pathology , alternative medicine

Osteoporosis afflicts a large number of populations in the world and is featured by systemic impairment of bone mass and strength which may further trigger an increase in the risk of fragile fractures. This network meta-analysis (NMA) is designed to distinguish therapies more preferable than others with respect to efficacy and safety.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research